Identification and management of severe multiple radiation-induced heart disease: case reports from locally advanced esophageal cancer patient

Yi-Xun GU; Xi-Zhi ZHANG; Jun LI; Yong CHEN

doi:10.11909/j.issn.1671-5411.2021.02.010

Volume 18 Issue 2

Mar. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Geriatric Cardiology > 2021 > 18(2): 141-145

Please cite this article as: GU YX, ZHANG XZ, LI J, CHEN Y. Identification and management of severe multiple radiation-induced heart disease: case reports from locally advanced esophageal cancer patient. J Geriatr Cardiol 2021; 18(2): 141−145. DOI: 10.11909/j.issn.1671-5411.2021.02.010

Citation:

Please cite this article as: GU YX, ZHANG XZ, LI J, CHEN Y. Identification and management of severe multiple radiation-induced heart disease: case reports from locally advanced esophageal cancer patient. J Geriatr Cardiol 2021; 18(2): 141−145. DOI: 10.11909/j.issn.1671-5411.2021.02.010

Citation:

PDF( 17582 KB)

Identification and management of severe multiple radiation-induced heart disease: case reports from locally advanced esophageal cancer patient

doi: 10.11909/j.issn.1671-5411.2021.02.010

1.
Clinical Medical College, Yangzhou University, Jiangsu, China
2.
Department of Oncology, Northern Jiangsu Province People Hospital of Yangzhou University, Jiangsu, China
3.
Department of Oncology, Affiliated Hospital of Yangzhou University, Jiangsu, China

More Information

Corresponding author: chenyong_jsyz@sina.com
Available Online: 2020-12-31
Publish Date: 2021-03-05

Abstract

FullText(HTML)

References(9)

References

[1]	GBD 2017 Oesophageal Cancer Collaborators. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020; 5: 582−597. doi: 10.1016/S2468-1253(20)30007-8
[2]	Tadic M, Cuspidi C, Hering D, et al. Radiotherapy-induced right ventricular remodelling: the missing piece of the puzzle. Arch Cardiovasc Dis 2017; 110: 116−123. doi: 10.1016/j.acvd.2016.10.003
[3]	Zamorano JL, Lancellotti P, Rodriguez Muñoz D, et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J 2016; 37: 2768−2801. doi: 10.1093/eurheartj/ehw211
[4]	Liu LK, Ouyang W, Zhao X, et al. Pathogenesis and prevention of radiation-induced myocardial fibrosis. Asian Pac J Cancer Prev 2017; 18: 583−587. doi: 10.22034/APJCP.2017.18.3.583
[5]	Yeneneh BT, Allen S, Panse P, et al. Constrictive pericarditis 5 months after radiation therapy in a 62-year-old woman with esophageal cancer. Tex Heart Inst J 2017; 44: 411−415. doi: 10.14503/THIJ-16-6054
[6]	Hayashi Y, Iijima H, Isohashi F, et al. The heart’s exposure to radiation increases the risk of cardiac toxicity after chemoradiotherapy for superficial esophageal cancer: a retrospective cohort study. BMC Cancer 2019; 19: 195. doi: 10.1186/s12885-019-5421-y
[7]	Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart 2009; 95: 252−258. doi: 10.1136/hrt.2008.149088
[8]	Totzeck M, Schuler M, Stuschke M, et al. Cardio-oncology—strategies for management of cancer-therapy related cardiovascular disease. Int J Cardiol 2019; 280: 163−175. doi: 10.1016/j.ijcard.2019.01.038
[9]	Ma LY, Chen WW, Gao RL, et al. China cardiovasular diseases report 2018: an updated summary. J Geriatr Cardiol 2020; 17: 1−8. doi: 10.11909/j.issn.1671-5411.2020.01.001